Amedisys (NASDAQ:AMED) Shares Gap Up – Should You Buy?

Amedisys, Inc. (NASDAQ:AMED)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $85.95, but opened at $89.50. Amedisys shares last traded at $89.46, with a volume of 536,164 shares trading hands.

Amedisys Stock Performance

The company has a market capitalization of $2.94 billion, a price-to-earnings ratio of 35.64, a PEG ratio of 1.84 and a beta of 0.73. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The stock has a 50 day simple moving average of $90.60 and a two-hundred day simple moving average of $94.44.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). The business had revenue of $587.67 million for the quarter, compared to analysts’ expectations of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Amedisys’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.98 EPS. As a group, analysts anticipate that Amedisys, Inc. will post 4.45 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of AMED. Oddo BHF Asset Management Sas purchased a new stake in Amedisys in the third quarter valued at $7,238,000. Barclays PLC lifted its holdings in shares of Amedisys by 49.5% in the 3rd quarter. Barclays PLC now owns 15,529 shares of the health services provider’s stock valued at $1,500,000 after purchasing an additional 5,142 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Amedisys by 1.3% in the 3rd quarter. Geode Capital Management LLC now owns 567,105 shares of the health services provider’s stock valued at $54,746,000 after purchasing an additional 7,071 shares during the period. National Bank of Canada FI grew its stake in Amedisys by 119.0% during the 3rd quarter. National Bank of Canada FI now owns 55,592 shares of the health services provider’s stock worth $5,365,000 after buying an additional 30,213 shares during the last quarter. Finally, Quantinno Capital Management LP grew its stake in Amedisys by 60.4% during the 3rd quarter. Quantinno Capital Management LP now owns 40,457 shares of the health services provider’s stock worth $3,905,000 after buying an additional 15,238 shares during the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.